241 related articles for article (PubMed ID: 29181706)
1. Self-Assembling Raloxifene Loaded Mixed Micelles: Formulation Optimization, In Vitro Cytotoxicity and In Vivo Pharmacokinetics.
Kanade R; Boche M; Pokharkar V
AAPS PharmSciTech; 2018 Apr; 19(3):1105-1115. PubMed ID: 29181706
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
3. Harmine-loaded galactosylated pluronic F68-gelucire 44/14 mixed micelles for liver targeting.
Prasad Kushwaha J; Baidya D; Patil S
Drug Dev Ind Pharm; 2019 Aug; 45(8):1361-1368. PubMed ID: 31096800
[TBL] [Abstract][Full Text] [Related]
4. Chrysin-loaded folate conjugated PF127-F68 mixed micelles with enhanced oral bioavailability and anticancer activity against human breast cancer cells.
Baidya D; Kushwaha J; Mahadik K; Patil S
Drug Dev Ind Pharm; 2019 May; 45(5):852-860. PubMed ID: 30724621
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
Jain A; Sharma T; Kumar R; Katare OP; Singh B
Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
[TBL] [Abstract][Full Text] [Related]
6. QbD-based optimization of raloxifene-loaded cubosomal formulation for transdemal delivery: ex vivo permeability and in vivo pharmacokinetic studies.
Gupta T; Kenjale P; Pokharkar V
Drug Deliv Transl Res; 2022 Dec; 12(12):2979-2992. PubMed ID: 35462597
[TBL] [Abstract][Full Text] [Related]
7. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Saini D; Fazil M; Ali MM; Baboota S; Ali J
Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
[TBL] [Abstract][Full Text] [Related]
8. In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance.
Ahmed OA; Badr-Eldin SM
Int J Nanomedicine; 2018; 13():6325-6335. PubMed ID: 30349253
[TBL] [Abstract][Full Text] [Related]
9. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.
Zhao J; Xu Y; Wang C; Ding Y; Chen M; Wang Y; Peng J; Li L; Lv L
Drug Dev Ind Pharm; 2017 Jul; 43(7):1197-1204. PubMed ID: 28300426
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers.
Hou J; Wang J; Sun E; Yang L; Yan HM; Jia XB; Zhang ZH
Drug Deliv; 2016 Nov; 23(9):3248-3256. PubMed ID: 26984338
[TBL] [Abstract][Full Text] [Related]
11. Optimized semisolid self-nanoemulsifying system based on glyceryl behenate: A potential nanoplatform for enhancing antitumor activity of raloxifene hydrochloride in MCF-7 human breast cancer cells.
Badr-Eldin SM; Aldawsari HM; Ahmed OAA; Alhakamy NA; Neamatallah T; Okbazghi SZ; Fahmy UA
Int J Pharm; 2021 May; 600():120493. PubMed ID: 33744452
[TBL] [Abstract][Full Text] [Related]
12. Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
Du X; Gao N; Song X
Drug Deliv; 2021 Dec; 28(1):252-260. PubMed ID: 33501870
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and pharmacokinetics study of a novel genistein-loaded mixed micelles system.
Shen H; He D; Wang S; Ding P; Wang J; Ju J
Drug Dev Ind Pharm; 2018 Sep; 44(9):1536-1542. PubMed ID: 29848136
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the oral bioavailability of baicalein via Solutol
Shen H; Liu Y; Zhang H; Ding P; Zhang L; Zhang L; Ju J
J Pharm Pharmacol; 2019 May; 71(5):765-773. PubMed ID: 30549042
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630.
Wu X; Ge W; Shao T; Wu W; Hou J; Cui L; Wang J; Zhang Z
Int J Nanomedicine; 2017; 12():1475-1483. PubMed ID: 28260893
[TBL] [Abstract][Full Text] [Related]
16. Enhanced in vitro cytotoxicity and anti-tumor activity of vorinostat-loaded pluronic micelles with prolonged release and reduced hepatic and renal toxicities.
Mohamed EA; Abu Hashim II; Yusif RM; Suddek GM; Shaaban AAA; Badria FAE
Eur J Pharm Sci; 2017 Jan; 96():232-242. PubMed ID: 27667706
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT
Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal model.
Ansari MD; Shafi S; Pandit J; Waheed A; Jahan RN; Khan I; Vohora D; Jain S; Aqil M; Sultana Y
Drug Deliv Transl Res; 2024 Jun; 14(6):1635-1647. PubMed ID: 37996726
[TBL] [Abstract][Full Text] [Related]
19. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.
Elsheikh MA; Elnaggar YS; Gohar EY; Abdallah OY
Int J Nanomedicine; 2012; 7():3787-802. PubMed ID: 22888234
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability of raloxifene hydrochloride via dry suspensions prepared from drug/HP-β-cyclodextrin inclusion complexes.
Lu R; Liu S; Wang Q; Li X
Pharmazie; 2015 Dec; 70(12):791-7. PubMed ID: 26817276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
